Aura phenomenon: a proposal for an etiology-based clinical classification [0.03%]
aura现象：一种基于病因的临床分类建议
Umberto Pensato,Andrew M Demchuk,Jens P Dreier et al.
Umberto Pensato et al.
Background: The term "aura" refers to a well-defined pattern of usually positive, progressive, and reversible neurological symptoms, with spreading depolarization as the underlying mechanism. While commonly associated wit...
The burden of headache disorders among medical students in Vietnam: estimates from a cross-sectional study with a health-care needs assessment [0.03%]
越南医学生头痛障碍负担估计值：一项卫生需求评估横断面研究结果
Dung Viet Nguyen,Hieu Trung Vo,Khoi Hong Vo et al.
Dung Viet Nguyen et al.
Background: In our previous study, we demonstrated that headaches are highly prevalent among medical students in Vietnam. In the present study, we provide estimates of the associated symptom burden and impaired participat...
Consistency between headache diagnoses and ICHD-3 criteria across different levels of care [0.03%]
不同层级医疗机构之间偏头痛诊断与ICHD-3标准一致性分析
Lucas Hendrik Overeem,Marlene Ulrich,Mira Pauline Fitzek et al.
Lucas Hendrik Overeem et al.
Background: Diagnosing headache disorders poses significant challenges, particularly in primary and secondary levels of care (PSLC), potentially leading to misdiagnosis and underdiagnosis. This study evaluates diagnostic ...
A robust multimodal brain MRI-based diagnostic model for migraine: validation across different migraine phases and longitudinal follow-up data [0.03%]
一种基于多模态脑MRI的偏头痛诊断模型：在不同偏头痛阶段和纵向随访数据中的验证
Jong Young Namgung,Eunchan Noh,Yurim Jang et al.
Jong Young Namgung et al.
Inter-individual variability in symptoms and the dynamic nature of brain pathophysiology present significant challenges in constructing a robust diagnostic model for migraine. In this study, we aimed to integrate different types of magnetic...
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) [0.03%]
瑞美吉泮治疗急性偏头痛的疗效和耐受性：一项真实世界、前瞻性、多中心研究（GAINER研究）
Luigi Francesco Iannone,Gloria Vaghi,Gabriele Sebastianelli et al.
Luigi Francesco Iannone et al.
Background: Rimegepant, a novel oral calcitonin gene-related peptide receptor antagonist, has been recently approved for the acute migraine treatment. While its efficacy was confirmed in randomized clinical trials, no dat...
Multicenter Study
The journal of headache and pain. 2025 Jan 6;26(1):4. DOI:10.1186/s10194-024-01935-8 2025
Migraine in men [0.03%]
男性 migraine 病患
Mira P Fitzek,Deirdre M Boucherie,Tessa de Vries et al.
Mira P Fitzek et al.
Background: Migraine is a common primary headache disorder, less frequently affecting men than women, and often regarded as predominantly a "women's disease." Despite this, migraine in men presents with unique characteris...
Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members' vision - part 2 [0.03%]
下一代人工智能对未来头痛研究、诊断和治疗的影响——青年编委视角（二）
Igor Petrušić,Chia-Chun Chiang,David Garcia-Azorin et al.
Igor Petrušić et al.
Part 2 explores the transformative potential of artificial intelligence (AI) in addressing the complexities of headache disorders through innovative approaches, including digital twin models, wearable healthcare technologies and biosensors,...
Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial [0.03%]
替佐单抗治疗患者疼痛和功能残疾的长期减少：BHV3500-301期3随机对照试验的事后分析
Lauren Powell,Fiona O&#x;Sullivan,Pramoda Jayasinghe et al.
Lauren Powell et al.
Background: Migraine is a disabling disorder that impacts 40 million people in the US. Zavegepant is the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal-spray approved for the acute treatment of mig...
The burden of headache disorders in the adult population of Morocco: estimates, and a health-care needs assessment, from a cross-sectional population-based door-to-door survey [0.03%]
摩洛哥成人人口中头痛疾病的负担：一项基于人群的入户调查估算及卫生需求评估
Najib Kissani,Latifa Adarmouch,Aboubacar Sidik Sidibe et al.
Najib Kissani et al.
Background: We have previously shown headache disorders to be prevalent in in the adult general population of Morocco, especially migraine (30.8%) and headache on ≥ 15 days/month (H15+; 10.5%). This study, collecting dat...
Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022 [0.03%]
2018年至2022年哥伦比亚偏头痛患者流行病学、临床特征及治疗模式研究
A C Rubio,J A Arciniegas,J E Bolanos-Lopez et al.
A C Rubio et al.
Background: To describe the epidemiology and clinical characteristics of migraine and the status of treatment in Colombia. Additionally, the use of health resources by patients was measured. ...